Fund shareholders of Supernus Pharmaceuticals Inc
ISIN US8684591089 · United States · LEI 549300GRM36VBKISYJ58
- Fund shareholders
- 356
- Of which ETFs
- 94 262 other funds
- Value held
- 1.3B $ 260.4K € · 9.4M SEK
- Share of capital
- 44.0 % of 58.1M shares on Jul 28, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Avantis U.S. Equity Fund American Century ETF Trust | 1,246 | 68.2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,237 | 59.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AQR Small Cap Multi-Style Fund AQR Funds | 1,151 | 59.5K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Small Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 1,119 | 57.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 1,041 | 57K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Schwab Fundamental U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 984 | 53.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Putnam Multi-Asset Income Fund Putnam Asset Allocation Funds | 892 | 48.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 889 | 46K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 834 | 40K $ | 1.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| The U.S. Equity Portfolio HC Capital Trust | 803 | 41.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 796 | 41.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALLCAP GROWTH ProFunds | 789 | 40.8K $ | 0.27 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Value Tilt ETF SPDR SERIES TRUST | 763 | 39.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Franklin Allocation Moderately Aggressive Portfolio SEASONS SERIES TRUST | 728 | 37.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 725 | 37.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 701 | 38.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Acclivity Small Cap Value Fund NORTHERN LIGHTS FUND TRUST II | 652 | 33.7K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra SmallCap600 ProShares Trust | 628 | 34.4K $ | 0.14 % | 0.00 % | as of Feb 28, 2026 ↗ |
| American Century Small Cap Value Insights ETF American Century ETF Trust | 626 | 34.3K $ | 0.39 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 623 | 29.9K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 602 | 31.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 600 | 31K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam VT Global Asset Allocation Fund Putnam Variable Trust | 484 | 25K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALLCAP VALUE ProFunds | 446 | 23.1K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P SmallCap 600 ESG ETF SPDR SERIES TRUST | 444 | 23K $ | 0.32 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 443 | 24.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 347 | 17.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 341 | 16.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 328 | 17K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 300 | 15.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 297 | 14.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 275 | 14.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 268 | 13.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 257 | 13.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Gotham Enhanced Return Fund FundVantage Trust | 224 | 11.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Pacer S&P SmallCap 600 Quality FCF Aristocrats ETF Pacer Funds Trust | 216 | 10.4K $ | 0.67 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 214 | 10.3K $ | 0.22 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 191 | 9.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 185 | 9.6K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 180 | 8.6K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 180 | 8.6K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 140 | 7.2K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 123 | 6.4K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP VALUE PROFUND ProFunds | 122 | 5.9K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 111 | 5.3K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity Covington Trust | 101 | 5.2K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 101 | 4.8K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 83 | 4.3K $ | 0.14 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 74 | 3.8K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 55 | 3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 40 | 2.2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Founders 100 ETF Founder Funds Trust | 33 | 1.7K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 18 | 985.1 $ | 0.09 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 14 | 723.7 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 133.5K € | 1.02 % | as of Dec 31, 2025 ↗ | ||
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 126.9K € | 0.95 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.46 % | as of Mar 31, 2026 ↗ |
| Third Avenue Small-Cap Value Fund Third Avenue Trust | 3.64 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 2.78 % | as of Apr 30, 2026 ↗ |
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 2.64 % | as of Apr 30, 2026 ↗ |
| AMG GW&K Small Cap Value Fund AMG Funds | 2.27 % | as of Mar 31, 2026 ↗ |
| abrdn Focused U.S. Small Cap Active ETF abrdn Funds | 1.93 % | as of Apr 30, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 1.87 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.86 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.79 % | as of Mar 31, 2026 ↗ |
| AMG GW&K Small Cap Core Fund AMG Funds | 1.74 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 353 | +6 | 25,578,142 | -1.2 % |
| 2026Q1 | 347 | -5 | 25,883,757 | -3.1 % |
| 2025Q4 | 352 | +24 | 26,703,697 | -6.8 % |
| 2025Q3 | 328 | +3 | 28,660,879 | -2.8 % |
| 2025Q2 | 325 | +13 | 29,476,356 | -3.2 % |
| 2025Q1 | 312 | +7 | 30,453,615 | +4.6 % |
| 2024Q4 | 305 | +10 | 29,107,606 | -2.1 % |
| 2024Q3 | 295 | +2 | 29,732,314 | +3.3 % |
| 2024Q2 | 293 | +3 | 28,772,080 | +5.9 % |
| 2024Q1 | 290 | -10 | 27,167,042 | -4.5 % |
| 2023Q4 | 300 | 28,446,884 |
Institutional managers
317 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 8,797,254 | 454.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,315,973 | 171.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 2,307,030 | 119.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,288,127 | 118.3M $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2,037,202 | 105.3M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,895,347 | 98M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,705,222 | 88.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,623,514 | 83.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,493,446 | 77.2M $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 1,425,779 | 73.7M $ | as of Mar 31, 2026 |
| Stephens Investment Management Group LLC | 1,351,331 | 69.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,318,555 | 68.2M $ | as of Mar 31, 2026 |
| GW&K Investment Management, LLC | 1,055,184 | 54.5K $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 954,309 | 49.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 913,893 | 47.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 856,487 | 44.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 714,226 | 36.9M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 705,976 | 36.5M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 699,456 | 36.2M $ | as of Mar 31, 2026 |
| ASHFORD CAPITAL MANAGEMENT INC | 645,381 | 33.4M $ | as of Mar 31, 2026 |
| Freestone Grove Partners LP | 641,319 | 33.1M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 622,450 | 32.2M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 530,618 | 27.4M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 502,406 | 26M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 498,198 | 25.8M $ | as of Mar 31, 2026 |
Declared shareholders of Supernus Pharmaceuticals Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 5.66 % | 3,263,309 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.03 % | 2,900,884 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Supernus Pharmaceuticals Inc". https://titelia.com/en/stocks/supernus-pharmaceuticals-inc-US8684591089